Kalaris Therapeutics (KLRS) Financials: Revenue & Earnings
KLRS$1.92+0.06 +3.23%
$41.93M
Market Cap
—
P/E
—
Forward P/E
—
Score
Kalaris Therapeutics (KLRS) Financials: Revenue & Earnings
KLRS price $1.92 +0.06 +3.23%
- Ticker
- KLRS
- Price
- $1.92
- Change
- +0.06 +3.23%
- Market cap ?
- $41.93M
- Beta ?
- 0.21
- Sector
- Healthcare
- Industry
- Biotechnology
Fair value
KLRS fair value Not meaningful. Price $1.92.
Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price. How discounted cash flow works.
Not meaningful
Earnings
| Date | EPS actual | EPS estimate | Revenue | Revenue estimate |
|---|---|---|---|---|
| 2026-11-11 | — | -0.52 | — | — |
| 2026-08-11 | -0.48 | -0.49 | — | — |
| 2026-05-12 | -0.46 | -0.52 | — | — |
| 2026-03-17 | -0.44 | -0.56 | — | — |
| 2025-11-12 | -0.64 | -0.66 | — | — |
| 2025-08-13 | -0.61 | -0.51 | — | — |
| 2025-05-14 | -2.52 | -0.78 | — | — |
| 2025-03-07 | -3.64 | -2.76 | — | — |
| 2024-11-12 | -0.04 | -0.14 | — | — |
| 2024-06-30 | -1.13 | -2.37 | — | — |
| 2024-05-13 | -5.98 | -3.62 | — | — |
| 2023-12-31 | -0.70 | -9.84 | — | — |
| 2023-09-30 | -8.94 | — | — | — |
| 2023-06-30 | -11.00 | — | — | — |
| 2023-03-31 | -10.15 | — | — | — |
| 2022-12-31 | -9.42 | — | — | — |
| 2022-09-30 | -11.39 | — | — | — |
| 2022-06-30 | -15.93 | — | — | — |
| 2022-03-31 | -15.76 | — | — | — |
| 2021-12-31 | -20.96 | — | — | — |
| 2021-09-30 | -16.62 | — | — | — |
| 2021-06-30 | -13.87 | — | — | — |
| 2021-03-31 | -11.44 | — | — | — |
| 2020-12-31 | -9.36 | — | — | — |
| 2020-09-30 | -13.42 | — | — | — |
| 2020-06-30 | -4.11 | — | — | — |
| 2020-03-31 | -3.30 | — | — | — |
| 2019-12-31 | -3.09 | — | — | — |
| 2019-09-30 | -2.57 | — | — | — |
| 2019-06-30 | -1.87 | — | — | — |
| 2019-03-31 | -0.89 | — | 165.00K | — |
Dividends
Yield 0.00%. Payout ratio 0.00%. Frequency —.
Safety score 37/100 · Watch. Payout ratio is 0% of earnings. Free-cash-flow coverage is not available, so this part stays neutral. No dividend history was found. There is no dividend yield.
| Ex-date | Dividend | Record | Payment | Frequency |
|---|---|---|---|---|
| No data yet. | ||||
Insider trades
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| 2026-08-27 | Vandekop Amy O'Leary | Buy | 10.00K | $4.10 | 41.00K |
| 2026-08-01 | KEATING LAURIE | Buy | 18.00K | $3.51 | 63.18K |
| 2026-08-01 | KEATING LAURIE | Other | 0 | — | — |
| 2026-07-27 | Vandekop Amy O'Leary | Other | 0 | — | — |
| 2026-07-27 | Vandekop Amy O'Leary | Other | 27.41K | $7.31 | 200.40K |
| 2026-07-27 | Vandekop Amy O'Leary | Other | 20.00K | $6.81 | 136.20K |
| 2026-07-20 | Bayko Liisa Ann | Buy | 220.00K | $4.00 | 880.00K |
| 2026-07-20 | Bayko Liisa Ann | Other | 0 | — | — |
| 2026-06-03 | Jovan-Embiricos Morana | Buy | 9.00K | $4.72 | 42.48K |
| 2026-06-03 | Ferrara Napoleone | Buy | 9.00K | $4.72 | 42.48K |
| 2026-06-03 | Hallal David | Buy | 9.00K | $4.72 | 42.48K |
| 2026-06-03 | AKKARAJU SRINIVAS | Buy | 9.00K | $4.72 | 42.48K |
| 2026-06-03 | Dybbs Michael | Buy | 9.00K | $4.72 | 42.48K |
| 2026-06-03 | ADAMIS ANTHONY P | Buy | 9.00K | $4.72 | 42.48K |
| 2026-06-03 | PATTERSON LEONE D | Buy | 9.00K | $4.72 | 42.48K |
| 2026-05-20 | AKKARAJU SRINIVAS | Sell | 66.91K | — | — |
| 2026-05-20 | AKKARAJU SRINIVAS | Buy | 244.30K | $4.83 | 1.18M |
| 2026-05-20 | AKKARAJU SRINIVAS | Buy | 4.47K | — | — |
| 2026-05-20 | AKKARAJU SRINIVAS | Buy | 14.94K | — | — |
| 2026-03-20 | Hagen Brett R | Sell | 1.92K | $6.72 | 12.87K |
| 2026-03-19 | Hagen Brett R | Buy | 60.80K | $6.81 | 414.05K |
| 2026-03-19 | Oxtoby Andrew | Buy | 222.00K | $6.81 | 1.51M |
| 2026-03-19 | Gall Matthew | Buy | 95.00K | $6.81 | 646.95K |
| 2026-03-19 | Feinsod Matthew | Buy | 135.00K | $6.81 | 919.35K |
| 2025-12-22 | AKKARAJU SRINIVAS | Buy | 1.50M | $10.00 | 15.00M |
| 2025-12-18 | AKKARAJU SRINIVAS | Buy | 479.85K | $10.42 | 5.00M |
| 2025-11-03 | Gall Matthew | Buy | 235.00K | $4.99 | 1.17M |
| 2025-11-03 | Gall Matthew | Other | 0 | — | — |
| 2025-04-10 | Hagen Brett R | Buy | 50.26K | $7.31 | 367.42K |
| 2025-04-10 | AKKARAJU SRINIVAS | Buy | 18.00K | $7.31 | 131.58K |
| 2025-04-10 | Jovan-Embiricos Morana | Buy | 18.00K | $7.31 | 131.58K |
| 2025-04-10 | PATEL SAMIR CHANDRAKANT | Buy | 18.00K | $7.31 | 131.58K |
| 2025-04-10 | Ferrara Napoleone | Buy | 18.00K | $7.31 | 131.58K |
| 2025-04-10 | Oxtoby Andrew | Buy | 287.00K | $7.31 | 2.10M |
| 2025-04-10 | ADAMIS ANTHONY P | Buy | 18.00K | $7.31 | 131.58K |
| 2025-04-10 | Feinsod Matthew | Buy | 101.00K | $7.31 | 738.31K |
| 2025-04-10 | Feinsod Matthew | Buy | 70.55K | $7.31 | 515.73K |
| 2025-04-10 | PATTERSON LEONE D | Buy | 18.00K | $7.31 | 131.58K |
| 2025-04-03 | PATTERSON LEONE D | Other | 0 | — | — |
| 2025-03-26 | Hagen Brett R | Sell | 907 | $8.97 | 8.14K |
| 2025-03-18 | AKKARAJU SRINIVAS | Other | 0 | — | — |
| 2025-03-18 | Samsara BioCapital GP, LLC | Other | 0 | — | — |
| 2025-03-18 | Ferrara Napoleone | Buy | 504.00K | — | — |
| 2025-03-18 | PATEL SAMIR CHANDRAKANT | Buy | 252.00K | — | — |
| 2025-03-18 | PATEL SAMIR CHANDRAKANT | Buy | 105.91K | $0.85 | 90.03K |
| 2025-03-18 | PATEL SAMIR CHANDRAKANT | Buy | 100.80K | — | — |
| 2025-03-18 | Feinsod Matthew | Buy | 28.22K | $0.85 | 23.99K |
| 2025-03-18 | Feinsod Matthew | Buy | 4.03K | — | — |
| 2025-03-18 | Oxtoby Andrew | Buy | 476.61K | $0.85 | 405.12K |
| 2025-03-18 | AKKARAJU SRINIVAS | Buy | 11.44M | — | — |
| 2025-03-18 | ADAMIS ANTHONY P | Buy | 19.48K | $0.55 | 10.72K |
| 2025-03-18 | ADAMIS ANTHONY P | Buy | 12.99K | $0.55 | 7.14K |
| 2025-03-18 | AKKARAJU SRINIVAS | Other | 0 | — | — |
| 2025-03-18 | Ferrara Napoleone | Other | 0 | — | — |
| 2025-03-18 | Dybbs Michael | Other | 0 | — | — |
| 2025-03-18 | PATEL SAMIR CHANDRAKANT | Other | 0 | — | — |
| 2025-03-18 | Oxtoby Andrew | Other | 0 | — | — |
| 2025-03-18 | Feinsod Matthew | Other | 0 | — | — |
| 2025-03-18 | ADAMIS ANTHONY P | Other | 0 | — | — |
Institutional holders
Latest filed quarter: Q2 2026.
Institutions holding: 56, holders -2 vs prior quarter. Ownership 75.79%.
| Holder | Shares | Change | Change % | Value |
|---|---|---|---|---|
| SAMSARA BIOCAPITAL, LLC | 12.88M | -66.91K | -0.52% | 52.43M |
| RTW INVESTMENTS, LP | 1.30M | 0 | 0.00% | 5.29M |
| ALYESKA INVESTMENT GROUP, L.P. | 572.69K | 0 | 0.00% | 2.33M |
| SIREN, L.L.C. | 435.80K | 0 | 0.00% | 1.77M |
| VANGUARD CAPITAL MANAGEMENT LLC | 398.71K | 143.36K | +56.14% | 1.62M |
| IKARIAN CAPITAL, LLC | 360.00K | 0 | 0.00% | 1.47M |
| UBS GROUP AG | 262.13K | 255.95K | +4138.86% | 1.07M |
| RENAISSANCE TECHNOLOGIES LLC | 149.35K | 83.20K | +125.77% | 607.86K |
| MARSHALL WACE, LLP | 139.20K | 71.32K | +105.07% | 566.55K |
| GEODE CAPITAL MANAGEMENT, LLC | 114.04K | 26.49K | +30.26% | 464.29K |
| ADAR1 CAPITAL MANAGEMENT, LLC | 100.00K | 0 | 0.00% | 407.00K |
| WOODLINE PARTNERS LP | 100.00K | 0 | 0.00% | 407.00K |
| WHI TRUST CO LLC | 97.49K | 0 | 0.00% | 396.80K |
| RAYMOND JAMES FINANCIAL INC | 97.16K | -21.72K | -18.27% | 395.46K |
| CITADEL ADVISORS LLC | 95.77K | 95.77K | New | 389.79K |
| BOOTHBAY FUND MANAGEMENT, LLC | 92.26K | 0 | 0.00% | 375.50K |
| VERDAD ADVISERS, LP | 80.30K | 80.30K | New | 326.81K |
| MORGAN STANLEY | 72.33K | 33.98K | +88.62% | 294.37K |
| VANGUARD FIDUCIARY TRUST CO | 66.18K | 29.46K | +80.24% | 269.35K |
| BLACKROCK, INC. | 54.44K | 18.40K | +51.05% | 221.58K |
| BELPOINTE ASSET MANAGEMENT LLC | 40.00K | 0 | 0.00% | 162.80K |
| FORTIS CAPITAL ADVISORS, LLC | 40.00K | 0 | 0.00% | 162.80K |
| PALE FIRE CAPITAL SE | 39.63K | 39.63K | New | 161.28K |
| SQUAREPOINT OPS LLC | 38.77K | -998 | -2.51% | 157.81K |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 32.50K | 10.00K | +44.44% | 132.28K |
Earnings and financials
Kalaris Therapeutics Inc (KLRS) trades at $1.92, with a market cap of $41.93M and a trailing P/E of n/a. Revenue below is the annual history on file. It describes what the business has already reported. It is not a forecast and it is not a recommendation.
Insights · Dividends · Forecast · Financials · Learn